Results 121 to 130 of about 44,968 (232)
ABSTRACT Emphysematous pyelonephritis is a rare, life‐threatening infection of the kidney characterized by necrosis and gas formation within the renal parenchyma, collecting system, and perinephric tissue. It commonly occurs in patients with poorly controlled type 2 diabetes mellitus (T2DM) and in those with obstructive nephropathy.
Daniel P. Mujuni +9 more
wiley +1 more source
ABSTRACT Endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy is an established treatment for choledocholithiasis but may rarely lead to pyogenic liver abscess (PLA). We report the case of a 72‐year‐old woman with a history of biliary stenting who presented with jaundice and cholestasis.
Yavor Asenov +7 more
wiley +1 more source
Improving Patient Decision-Making in Health Care [PDF]
Outlines regional variations within Minnesota in rates of patients with similar conditions receiving elective surgery, the concept of shared decision making, treatment choices for eight conditions, and steps for ensuring patients make informed ...
David C. Goodman +5 more
core
Integrated framework for tirzepatide in HFpEF management. Through metabolic, haemodynamic, structural and anti‐inflammatory pathways, tirzepatide modifies the disease trajectory of HFpEF, leading to improvements in symptoms, functional capacity and reduction in HF events.
Hamza A. Abdul‐Hafez +9 more
wiley +1 more source
ABSTRACT The optimal second‐line chemotherapy regimen for relapsed or refractory diffuse large B‐cell lymphoma (R/R DLBCL) remains uncertain. We retrospectively compared efficacy and safety between gemcitabine, carboplatin, dexamethasone, and rituximab (GCD‐R) and cyclophosphamide, high‐dose cytarabine, dexamethasone, etoposide, and rituximab (CHASER ...
Yoshikazu Ikoma +18 more
wiley +1 more source
Biliary infections: cholecystitis [PDF]
This issue of eMedRef provides information to clinicians on the pathophysiology, diagnosis, and therapeutics of ...
Kaapuraala, Abhishake
core
Rebalancing Hemostasis: Fitusiran as a First‐in‐Class RNAi Therapy in Hemophilia A and B
ABSTRACT Background and Aims Fitusiran is a first‐in‐class RNA interference (RNAi) therapy that lowers antithrombin (AT) to rebalance hemostasis in people with Hemophilia A or B, with or without inhibitors. Its recent FDA approval marks a major shift toward factor‐independent prophylaxis.
Raza Ur Rehman +2 more
wiley +1 more source
Salmonella Cholecystitis: Atypical Presentation of a Typical Condition [PDF]
Salmonella cholecystitis is a rare but important complication of Salmonella typhi infection. We are reporting an 11 years old female child who presented with complaints of high-grade fever, jaundice and right sided abdominal pain (Charcot\u27s triad ...
Ahmed, Shakeel +4 more
core +1 more source
ABSTRACT Background Gallbladder adenomyomatosis and polyps are common benign lesions that can mimic malignancy on imaging, often leading to unnecessary cholecystectomy. Despite frequent sonographic detection, the prevalence of adenomyomatosis in living cohorts remains poorly defined.
Marie Neumann +11 more
wiley +1 more source

